"We have patients who we’ve been following for over twenty years. We’re going to grow old together."
Where I see patients (3)
My work
Q&A: Walking patients back from the precipice
UCSF is known for excellent lung transplant outcomes, despite accepting the most challenging cases. Dr. Hays reveals what's behind the program's success.
My reviews
Selected research
-
Characterizing Risk Factors Associated With Recurrent Pleural Effusions in the Lung Transplant Recipients.
Journal of bronchology & interventional pulmonology
-
Evaluation of Crushed Posaconazole Delayed Release Tablets in Lung Transplant Recipients.
Transplant infectious disease : an official journal of the Transplantation Society
-
CD94+ natural killer cells potentiate pulmonary ischaemia-reperfusion injury.
The European respiratory journal
4.9